Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.

COVID-19 CT scan coronavirus hematologic malignancies hematology polymerase chain reaction screening

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 06 05 2020
accepted: 18 06 2020
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 29 7 2020
Statut: epublish

Résumé

COVID-19 has been declared a pandemic by the world health organization. Patients with cancer, and particularly hematologic malignancies may be at higher risk for severe complications due to their malignancy, immune dysregulation, therapy, and associated comorbidities. The oncology community has been proactive in issuing practice guidelines to help optimize management, and limit infection risk and complications from SARS-COV-2. Although hematologic malignancies account for only 10% of all cancers, their management is particularly complex, especially in the time of COVID-19. Screening or early detection of COVID-19 are central for preventative/mitigation strategy, which is the best current strategy in our battle against COVID-19. Herein, we provide an overview of COVID-19 screening strategies and highlight the unique aspects of treating patients with hematologic malignancies.

Identifiants

pubmed: 32719749
doi: 10.3389/fonc.2020.01267
pmc: PMC7348065
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1267

Informations de copyright

Copyright © 2020 Assi, Samra, Dercle, Rassy, Kattan, Ghosn, Houot and Ammari.

Références

J Am Coll Radiol. 2020 Jun;17(6):701-709
pubmed: 32283052
Med J Aust. 2020 Jun;212(10):481-489
pubmed: 32401360
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Radiology. 2020 Aug;296(2):E72-E78
pubmed: 32216717
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Nat Med. 2020 May;26(5):665-671
pubmed: 32405058
Clin Infect Dis. 2013 Jan;56(2):258-66
pubmed: 23024295
IEEE Trans Med Imaging. 2016 May;35(5):1207-1216
pubmed: 26955021
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
Oncologist. 2020 Jun;25(6):e936-e945
pubmed: 32243668
J Geriatr Oncol. 2020 Jun;11(5):764-768
pubmed: 32331928
Ann Oncol. 2020 Jul;31(7):894-901
pubmed: 32224151
Cancer Discov. 2020 Jun;10(6):783-791
pubmed: 32345594
Cancer Microenviron. 2011 Dec;4(3):313-23
pubmed: 21866321
Leuk Res. 2020 Mar 26;92:106353
pubmed: 32251934
Hematol Transfus Cell Ther. 2020 Apr - Jun;42(2):103-110
pubmed: 32313873
Radiology. 2020 Aug;296(2):E46-E54
pubmed: 32155105
Lancet. 2020 Feb 15;395(10223):e30-e31
pubmed: 32032529
Blood. 2020 May 21;135(21):1912-1915
pubmed: 32302379
Lancet Haematol. 2020 Apr;7(4):e351-e352
pubmed: 32220344
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Radiology. 2020 Aug;296(2):E65-E71
pubmed: 32191588
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Br J Haematol. 2016 May;173(3):380-93
pubmed: 27060988
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
Acta Haematol. 2020 Apr 17;:1-7
pubmed: 32305989
Cancer. 1980 Jun 1;45(11):2843-8
pubmed: 7379014
J Allergy Clin Immunol Pract. 2020 May;8(5):1489-1491
pubmed: 32220575
J Clin Oncol. 2020 Feb 10;38(5):415-422
pubmed: 31815579
J Am Acad Dermatol. 2020 Aug;83(2):703-704
pubmed: 32305443
Lancet Infect Dis. 2020 Apr;20(4):398-400
pubmed: 32113510
BMJ. 2020 Mar 23;368:m1165
pubmed: 32205334
Hematol Transfus Cell Ther. 2020 Apr - Jun;42(2):111-112
pubmed: 32292885
Br J Haematol. 2020 Apr;189(2):239-240
pubmed: 32180224
IEEE Rev Biomed Eng. 2020 Apr 16;:
pubmed: 32305937
Radiographics. 2013 Nov-Dec;33(7):1951-75
pubmed: 24224590
Blood Transfus. 2020 Mar;18(2):77-78
pubmed: 32267829
Oncotarget. 2017 Jan 10;8(2):3274-3288
pubmed: 27906678
Johns Hopkins Med J. 1976 Jul;139(1):1-12
pubmed: 820917
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Blood Adv. 2020 Apr 14;4(7):1307-1310
pubmed: 32243501
JAMA. 2020 Feb 21;:
pubmed: 32083643
Br J Haematol. 2020 Apr;189(2):241-243
pubmed: 32173855
Cell. 2018 Feb 22;172(5):1122-1131.e9
pubmed: 29474911
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
ESMO Open. 2020 Mar;5(2):
pubmed: 32229501
J Clin Virol. 2015 Jul;68:1-5
pubmed: 26071326
AJR Am J Roentgenol. 2020 Apr 16;:1-4
pubmed: 32298149
Biol Blood Marrow Transplant. 2020 Jul;26(7):1239-1246
pubmed: 32298807
Pediatr Hematol Oncol. 2011 Apr;28(3):176-86
pubmed: 21381869

Auteurs

Tarek Assi (T)

Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Bachar Samra (B)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Laurent Dercle (L)

Radiology Department, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY, United States.

Elie Rassy (E)

Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Joseph Kattan (J)

Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Marwan Ghosn (M)

Department of Hematology and Medical Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Roch Houot (R)

Department of Hematology, CHU de Rennes, Université de Rennes, Rennes, France.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

Samy Ammari (S)

Radiology Department, Gustave Roussy Cancer Campus, Villejuif, France.
BIOMAPS, UMR1281, INSERM.CEA.CNRS, Université Paris-Saclay, Paris, France.

Classifications MeSH